Menu
Recruiting NCT06564064

The Effect of Abdominal Binders on Patient's Wellbeing After Cesarean Delivery

No phase Interventional Effect of Abdominal Binders on Patient ( Pain, Quality of Recovery ) After Cesaean Section

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: abdominal binder.
Who it may be relevant to
Registry conditions: Effect of Abdominal Binders on Patient ( Pain, Quality of Recovery ) After Cesaean Section. Basic parameters: No limits · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Abdominal Binders on Patient's Wellbeing After Cesarean Delivery :a Prospective Comparative Study

Overview

The effect of abdominal binders on patient's wellbeing after cesarean delivery

Detailed description

The effect of abdominal binders on patient's wellbeing after cesarean delivery 12 hours and one week after cesarean section

Interventions

  • Device abdominal binder
    study group will be abdominal binders and control group will be control group , 12 hrs and one week later VAS and QOR 40 will assess patient,s wellbeing

Primary outcome measures

  • The effect of abdominal binders on pain after cesarean section [Time frame: 6 months]
Secondary outcome measures (1)
  • The effect of abdominal binders on patient's wellbeing after cesarean delivery [Time frame: one week postoperatively]

Eligibility criteria

Inclusion criteria

any female post cesarean section of singleton 34 wks gestaion fetus with previous cs

Exclusion criteria

primary cs any hypertensive disorder with pregnancy any neurologiacal disease general anasthesia or vertical incision

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sohag university Hospital — Sohag

Publications

  • Ghana S, Hakimi S, Mirghafourvand M, Abbasalizadeh F, Behnampour N. Randomized controlled trial of abdominal binders for postoperative pain, distress, and blood loss after cesarean delivery. Int J Gynaecol Obstet. 2017 Jun;137(3):271-276. doi: 10.1002/ijgo.12134. Epub 2017 Mar 28. PMID 28241386
  • Gustafson JL, Dong F, Duong J, Kuhlmann ZC. Elastic Abdominal Binders Reduce Cesarean Pain Postoperatively: A Randomized Controlled Pilot Trial. Kans J Med. 2018 May 18;11(2):1-19. eCollection 2018 May. PMID 29796155
  • Karaca I, Ozturk M, Alay I, Ince O, Karaca SY, Erdogan VS, Ekin M. Influence of Abdominal Binder Usage after Cesarean Delivery on Postoperative Mobilization, Pain and Distress: A Randomized Controlled Trial. Eurasian J Med. 2019 Oct;51(3):214-218. doi: 10.5152/eurasianjmed.2019.18457. PMID 31692751
  • Saeed S, Rage KA, Memon AS, Kazi S, Samo KA, Shahid S, Ali A. Use of Abdominal Binders after a Major Abdominal Surgery: A Randomized Controlled Trial. Cureus. 2019 Oct 3;11(10):e5832. doi: 10.7759/cureus.5832. PMID 31754567
  • Terkawi AS, Tsang S, Abolkhair A, Alsharif M, Alswiti M, Alsadoun A, AlZoraigi US, Aldhahri SF, Al-Zhahrani T, Altirkawi KA. Development and validation of Arabic version of the Short-Form McGill Pain Questionnaire. Saudi J Anaesth. 2017 May;11(Suppl 1):S2-S10. doi: 10.4103/sja.SJA_42_17. PMID 28615999
  • Terkawi AS, Myles PS, Riad W, Nassar SN, Mahmoud M, AlKahtani GJ, Sala FJ, Abdulrahman A, Doais KS, Terkawi RS, Tsang S. Development and validation of Arabic version of the postoperative quality of recovery-40 questionnaire. Saudi J Anaesth. 2017 May;11(Suppl 1):S40-S52. doi: 10.4103/sja.SJA_77_17. PMID 28616003

Identifiers

NCT: NCT06564064 · Soh-Med-24-07-20MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗